Please use this identifier to cite or link to this item:
|Title:||The Use of Procalcitonin as an Antimicrobial Stewardship Tool and a Predictor of Disease Severity in COVID-19.||Austin Authors:||Drewett, George P;Smibert, Olivia C ;Holmes, Natasha E ;Trubiano, Jason A||Affiliation:||Infectious Diseases||Issue Date:||25-Jan-2021||metadata.dc.date:||2021-01-25||Publication information:||Infection Control and Hospital Epidemiology 2021; online first: 25 January||Abstract:||In our study, procalcitonin was associated with both antibiotic use and duration in patients with COVID-19, as well as established biochemical markers of COVID-19 disease severity and oxygen requirement, suggesting a potential role for procalcitonin in COVID-19 antimicrobial stewardship.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/25753||DOI:||10.1017/ice.2021.28||ORCID:||0000-0002-9439-0251||PubMed URL:||33487208||Type:||Journal Article||Subjects:||PCT
|Appears in Collections:||Journal articles|
Show full item record
checked on May 6, 2021
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.